Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinomaYoshikawa, D; Ojima, H; Kokubu, A; Ochiya, T; Kasai, S; Hirohashi, S; Shibata, T · 2009

Targeted therapy against VEGFR and EGFR signaling with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic mouse model of human non-small cell lung cancerK. Shibuya; R. Komaki; W. Wu; T. Shintani; S. Itasaka; T. Isobe; A. Ryan; R.S. Herbst; M.S. O’Reilly · 2004

A5-02: Targeted therapy against VEGFR and/or EGFR signaling with AZD2171, vandetanib, and gefitinib as part of a combined modality approach for the treatment of non-small-cell lung cancerO'Reilly, Michael S.; Furutani, Kazuhisa; Wu, Wenjuan; Onn, Amir; Ryan, Anderson; Jürgensmeier, Juliane M.; Komaki, Ritsuko; Herbst, Roy S. · Journal of Thoracic Oncology · 2007

Gold medal recipientsInternational Journal of Radiation OncologyBiologyPhysics · 2004

2004 award winnersInternational Journal of Radiation OncologyBiologyPhysics · 2004

Schedule of events-tuesdayInternational Journal of Radiation OncologyBiologyPhysics · 2004

Radiation induced optic neuropathyBHANDARE, N; MONROE, A; MORRIS, C; MENDENHALL, W · International Journal of Radiation OncologyBiologyPhysics · 2004

Schedule of events-thursdayInternational Journal of Radiation OncologyBiologyPhysics · 2004

Keynote 3International Journal of Radiation OncologyBiologyPhysics · 2004

Index by authorInternational Journal of Radiation OncologyBiologyPhysics · 2004

Index by topicInternational Journal of Radiation OncologyBiologyPhysics · 2004